{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:00:42Z","timestamp":1792206042491,"version":"4.4.0"},"reference-count":49,"publisher":"National Academy of Sciences","issue":"8","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA228133"],"award-info":[{"award-number":["R01CA228133"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"HHS | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41EB028239"],"award-info":[{"award-number":["P41EB028239"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2020,2,25]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>There is an urgent need for improved cancer immunotherapies. The nanoparticles described here deliver genes to stimulate the immune system to specifically kill tumor cells. This synthetic, biodegradable system avoids the use of common gene delivery materials like viruses that can have safety concerns and manufacturing limitations. Local nanoparticle delivery evades adverse side effects stemming from systemic administration of immune-activating therapeutics. Importantly, this technology causes a tumor-targeting response but does not require prior knowledge of a particular patient\u2019s gene expression profile; thus, it can serve as a platform to combat many different solid cancers. Moreover, local nanoparticle administration causes a systemic cellular immune response, which has the potential to lead to better outcomes in the context of recurrence or metastasis.<\/jats:p>","DOI":"10.1073\/pnas.1916039117","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T19:55:22Z","timestamp":1581105322000},"page":"4043-4052","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":50,"title":["In situ genetic engineering of tumors for long-lasting and systemic immunotherapy"],"prefix":"10.1073","volume":"117","author":[{"given":"Stephany Y.","family":"Tzeng","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD 21231;"},{"name":"Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisha K.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD 21231;"},{"name":"Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD 21231;"},{"name":"Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall A.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD 21231;"},{"name":"Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD 21231;"},{"name":"Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD 21231;"},{"name":"Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD 21218;"},{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD 21218;"},{"name":"Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD 21218;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0571-0"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10673"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.05.005"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.162.6.3256","article-title":"Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells","volume":"162","author":"Curtsinger J. M.","year":"1999","unstructured":"J. M. Curtsinger ., Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162, 3256\u20133262 (1999).","journal-title":"J. Immunol."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1592"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001294"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70585-0"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2173"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.19017"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2014.06.007"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.155"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11705-017-1640-4"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.012"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/2051013614525375"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4910"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060031"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/832454"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120944"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00117"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99317"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018463"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.6.3112"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1107>3.0.CO;2-J"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b03218"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79915"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120638"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01386-7"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1523-1"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.09.007"},{"key":"e_1_3_3_30_2","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard J. P.","year":"1997","unstructured":"J. P. Leonard ., Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90, 2541\u20132548 (1997).","journal-title":"Blood"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.01.022"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1287"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.34616"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/nn501197v"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.13.204"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/09687860600790537"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/nn504905q"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0394-0"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152809787582507"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13520"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(05)80059-5"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7678351"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5687"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301034"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.03.384"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2016.05.040"},{"key":"e_1_3_3_47_2","first-page":"4641","article-title":"Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells","volume":"8","author":"Bhise N. S.","year":"2013","unstructured":"N. S. Bhise, K. J. Wahlin, D. J. Zack, J. J. Green, Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells. Int. J. Nanomedicine 8, 4641\u20134658 (2013).","journal-title":"Int. J. Nanomedicine"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.36033"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat9143"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1916039117","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1916039117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T09:45:50Z","timestamp":1695721550000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1916039117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,2,25]]}},"alternative-id":["10.1073\/pnas.1916039117"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1916039117","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"2020-02-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}